GlycoPEGylated Factor VIIa regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued positive opinions to grant Orphan Drug designation for Novo's GlycoPEGylated factor VIIa to treat hemophilia A and B. The pegylated formula...